United States  

'Dangerous dynamic': Coronavirus threatens new 'Cold War' between U.S. and China

USATODAY.com Tuesday, 5 May 2020
Near-daily blame-trading between the US and China over the covonavirus has led to warnings of a new "Cold War" brewing between the two superpowers.
0
shares
ShareTweetSavePostSend
 
Video Credit: Reuters Studio - Published
News video: Stocks slip as U.S. pins blame for virus on China

Stocks slip as U.S. pins blame for virus on China 01:41

European stock markets and oil prices fell Monday as a spat between top U.S. officials and China over the origin of the coronavirus fuelled fears of a new trade war, derailing a rebound in global markets. Ciara Lee reports

💡 One News Page Knowledge: Other News Mentions

Coronavirus Coronavirus Subfamily of viruses in the family Coronaviridae

Frontier CEO says CDC should update coronavirus travel advice: 'Flying is not dangerous'

The CDC says travel increases the chance of getting and spreading COVID-19. It also says most viruses don't spread easily on flights.

USATODAY.com

AP Top Stories August 7 A

Here's the latest for Friday August 7th: Coronavirus relief deal talks described as close to collapsing; Mexico records 50,000 coronavirus deaths; Unlawful..
USATODAY.com

CBS Evening News, August 6, 2020

Coronavirus model projects U.S. death toll could hit 300,000 by December;
CBS News

'We're very far apart': Coronavirus relief negotiations left in uncertainty after Congress leaves for the weekend

Both sides push for a compromise by the end of the week, but progress on a deal has bogged down.

USATODAY.com
Alcoholism treatment is potentially effective against COVID-19 [Video]

Alcoholism treatment is potentially effective against COVID-19

A team of chemists from HSE University and the Zelinsky Institute of Organic Chemistry used molecular modelling to find out that two medications that have been known for a long time can be used to fight SARS-CoV-2. These are disulfiram, which is used to treat alcoholism, and neratinib, an experimental drug being used to treat breast cancer. The paper about the discovery has been published online in the 4th issue of Mendeleev Communications journal.The structural elements of the virus that are less subject to mutation during its evolution should be chosen as a target for the potential treatment. Otherwise, a medication effective against one strain would no longer be effective against another. The best candidates for this are conservative proteins, such as the SARS-CoV-2 virus main protease M pro. In addition to being resistant to mutations, M pro plays a major role in coronavirusreplication, which means that its inhibition (blocking its function) is able to slow down or even completely stop its reproduction inside the body.Usually, the process of docking, as with a port dock and a ship entering it, is used for molecular modelling in simple cases. Two molecules participate in docking. One is called a 'ligand' (here, it is a medicine), and the other one is 'receptor' (or active site) of the target protein, such as Mpro, which can be used to 'dock'. An effective drug docks with the active site, by covalent links, which makes the enzyme dysfunctional or destroys it. But classical docking does not work in SARS-CoV-2.To overcome this problem, chemists from HSE University and the Zelinsky Institute decided to use 'on-top docking', which they came up with shortly before the pandemic. 'We decided not to focus on the previously described active site, but to investigate the whole surface of M pro protein with many medications, hoping that the big calculation powers would return useful "dockings",' - said Igor Svitanko, the author of the article,Professor at the HSE Joint Department of Organic Chemistry with the RAS Zelinsky Institute of Organic Chemistry.

Credit: ANI    Duration: 01:10Published

You Might Like


Related videos from verified sources

URSULA VON RYDINGSVARD INTO HER OWN Documentary movie [Video]

URSULA VON RYDINGSVARD INTO HER OWN Documentary movie

URSULA VON RYDINGSVARD INTO HER OWN Documentary movie trailer HD - Synopsis: URSULA VON RYDINGSVARD: INTO HER OWN is an artistic biography of one of the few women in the world working in monumental..

Credit: Teaser Trailer     Duration: 02:00Published
China Declares Itself ‘On the Brink of a New Cold War’ With the United States [Video]

China Declares Itself ‘On the Brink of a New Cold War’ With the United States

China Declares Itself ‘On the Brink of a New Cold War’ With the United States

Credit: Cerise Media English     Duration: 01:05Published
Trump touts new 'Super Duper Missile' [Video]

Trump touts new 'Super Duper Missile'

US President Donald Trump has touted what he calls his military's new ''Super-Duper MIssile, and says he has 'lost the flavour' for his country's trade deal with China signed in January, before the..

Credit: PA - Press Association STUDIO     Duration: 01:18Published

Related news from verified sources

11 critical, unanswered questions about the coronavirus and COVID-19, the diseases it causes

11 critical, unanswered questions about the coronavirus and COVID-19, the diseases it causes
· Experts continue to study the novel coronavirus as the number of people it infects and kills rises each day. · Scientists are increasingly certain the...
Business Insider

These are the 15 European health startups investors think will blow up during the coronavirus pandemic

These are the 15 European health startups investors think will blow up during the coronavirus pandemic
· *Health startups are in the spotlight as governments around the world struggle to contain the coronavirus pandemic. * · *Investors are eyeing disruptive...
Business Insider

Layoffs, imploding deals, and new opportunities. Here's everything you need to know about how the real-estate industry is transforming.

Layoffs, imploding deals, and new opportunities. Here's everything you need to know about how the real-estate industry is transforming.
· Offices, hotels, and malls have been emptied by the coronavirus, which could lead to more than 18 months of disruption in our day-to-day lives.  ·...
Business Insider


Tweets about this